Please login to the form below

Not currently logged in
Email:
Password:

EMA appoints Luc Vanheel as head of administration

He joins with immediate effect
Luc Vanheel

The European Medicines Agency (EMA) has named Luc Vanheel as the new head of its administration division.

Vanheel has previously worked as finance and business services director and deputy director and head of plans and programmes at the European Aviation Safety Agency (EASA), where he worked for six years.

He also worked his way from management reporting controller to a managing director over a 24-year period at Anheuser-Busch InBev, the world's largest brewer.

Deputy executive director Andreas Pott said: “EMA considers itself lucky to have gained Luc Vanheel as a new colleague and Head of Administration. Luc has ample managerial experience in both major private companies and in the European public sector. We are reassured that the challenging services he is taking over will be in good hands and that he will develop his vision of a modern, streamlined and ever more efficient administration.”

Vanheel will bring 30 years of experience in business administration in both the public and private sectors to the role, with a strong background in resource management, support services, strategic and budgetary planning and reporting.

Throughout his career, Vanheel has lived and worked in seven countries including Russia, Japan, Croatia, Belgium and Germany.

24th November 2014

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics